Article · Wikipedia archive · Last revised Jun 10, 2026

Mefruside

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.

Last revised
Jun 10, 2026
Read time
≈ 1 min
Length
105 w
Citations
1
Source
Wikipedia ↗
Mefruside
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.027.785
Chemical and physical data
FormulaC13H19ClN2O5S2
Molar mass382.87 g·mol−1
3D model (JSmol)
  • CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
  • InChI=1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18) ☒N
  • Key:SMNOERSLNYGGOU-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.1

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

References

  1. Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.